{"id":"W2138709799","doi":"10.1056/nejmoa1312542","title":"Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1737,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; Cambridge Institute for Medical Research, University of Cambridge; Medical Research Council; Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; Università degli Studi di Firenze; Vlaamse regering; Leukemia and Lymphoma Society; University of Southampton; University of Salford Manchester; University Hospital Southampton NHS Foundation Trust; Cancer Research UK; Kay Kendall Leukaemia Fund; Wellcome Trust; KU Leuven; National Institute for Health and Care Research; Leukemia and Lymphoma Research","keywords":"Calreticulin; Myelofibrosis; Essential thrombocythemia; Janus kinase 2; Biology; Polycythemia vera; Exome sequencing; Mutation; Germline mutation; Frameshift mutation; Myeloproliferative neoplasm; Cancer research; Myeloproliferative Disorders; Myeloid leukemia; Germline; Myeloid; Genetics; Gene; Immunology; Endoplasmic reticulum; Bone marrow","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}